Table 1. Baseline characteristics of study participants.
Variables | Controls N = 1112 | Possible HF* N = 135 | Probable HF† N = 121 | Definite HF N = 479 |
---|---|---|---|---|
Age, years | 75 ± 11 | 77 ± 11 | 78 ± 11 | 79 ± 11 |
Women, (%) | 647 (58) | 83 (61) | 66 (55) | 240 (50) |
Body Mass Index, kg/m2 | 26.5 ± 4.6 | 27.6 ± 6.9 | 28.4 ± 5.4 | 28.1 ± 5.5 |
Systolic Blood Pressure, mmHg | 137 ± 20 | 140 ± 25 | 140 ± 24 | 143 ± 24 |
Hypertension Treatment, (%) | 502 (45) | 75 (56) | 79 (66) | 323 (69) |
Current or Previous Diabetes, (%) | 118 (13) | 30 (31) | 25 (29) | 135 (37) |
Smoking, (%) | 89 (8) | 23 (17) | 14 (12) | 40 (8) |
Total cholesterol/HDL cholesterol ratio | 4.1 ± 1.4 | 4.1 ± 1.7 | 4.3 ± 1.7 | 4.4 ± 1.8 |
Estimated GFR, ml/min/1.73m2 | 68 ± 19 | 65 ± 19 | 63 ± 23 | 59 ± 22 |
Prevalent CHD‡, (%) | 84 (8) | 34 (25) | 48 (40) | 247 (52) |
Prevalent Lung Disease§, (%) | 145 (16) | 51 (44) | 37 (36) | 108 (27) |
Cells present mean ± SD for continuous variables and n (%) for categorical variables.
* Meet HF criteria but have an alternative explanation for findings.
† Do not meet full criteria for definite HF.
‡ Includes recognized myocardial infarction, coronary insufficiency and angina pectoris.
§Includes chronic obstructive pulmonary disease, chronic bronchitis, emphysema and asthma.
HF = heart failure; HDL = high density lipoprotein; GFR = glomerular filtration rate; CHD = coronary heart disease.